Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.
第一作者:
Nozomi,Niitsu
第一单位:
Department of Haematology, International Medical Centre, Saitama Medical University, Saitama Adult Lymphoma Treatment Study Group, Nagoya, Japan. nniitsu@saitama-med.ac.jp
作者:
主题词
成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);博来霉素(Bleomycin);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);流行病学方法(Epidemiologic Methods);依托泊甙(Etoposide);女(雌)性(Female);血液病(Hematologic Diseases);人类(Humans);淋巴瘤, T细胞, 外周(Lymphoma, T-Cell, Peripheral);男(雄)性(Male);中年人(Middle Aged);NM23核苷二磷酸激酶类(NM23 Nucleoside Diphosphate Kinases);肿瘤蛋白质类(Neoplasm Proteins);泼尼松龙(Prednisolone);预后(Prognosis);治疗结果(Treatment Outcome);长春新碱(Vincristine);青年人(Young Adult)
DOI
10.1111/j.1365-2141.2011.08634.x
PMID
21492124
发布时间
2015-11-19
- 浏览18
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文